MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b

Yangsheng Yu, Degang Guo, Lin Zhao

Open source

DOI
10.1155/2022/4364779
Published
2022-07-15
Container
Evidence-Based Complementary and Alternative Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/4364779,
  title = {MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b},
  author = {Yangsheng Yu and Degang Guo and Lin Zhao},
  year = {2022},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  doi = {10.1155/2022/4364779},
  url = {https://doi.org/10.1155/2022/4364779}
}

RIS

TY  - JOUR
TI  - MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b
AU  - Yangsheng Yu
AU  - Degang Guo
AU  - Lin Zhao
PY  - 2022
JO  - Evidence-Based Complementary and Alternative Medicine
DO  - 10.1155/2022/4364779
UR  - https://doi.org/10.1155/2022/4364779
ER  - 

APA

Yu, Y., Guo, D., & Zhao, L. (2022). MiR-199 Aggravates Doxorubicin-Induced Cardiotoxicity by Targeting TAF9b. Evidence-Based Complementary and Alternative Medicine. https://doi.org/10.1155/2022/4364779

Source records